|
FAM40A expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.19479999952199E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.184200E-04 |
| Normal-vs-Stage2 |
6.11939999999311E-05 |
| Normal-vs-Stage3 |
1.99409999623867E-09 |
| Normal-vs-Stage4 |
8.01869999955684E-07 |
| Stage1-vs-Stage2 |
1.232820E-01 |
| Stage1-vs-Stage3 |
1.343550E-03 |
| Stage1-vs-Stage4 |
2.289500E-02 |
| Stage2-vs-Stage3 |
4.570000E-01 |
| Stage2-vs-Stage4 |
7.385200E-01 |
| Stage3-vs-Stage4 |
6.838200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.99509999632141E-08 |
| Normal-vs-AfricanAmerican |
3.877800E-02 |
| Normal-vs-Asian |
5.280200E-01 |
| Caucasian-vs-AfricanAmerican |
3.144000E-02 |
| Caucasian-vs-Asian |
9.622500E-03 |
| AfricanAmerican-vs-Asian |
1.711840E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.18809999616332E-08 |
| Normal-vs-Female |
4.605600E-04 |
| Male-vs-Female |
9.164200E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.312040E-02 |
| Normal-vs-Age(41-60Yrs) |
4.3200000000021E-05 |
| Normal-vs-Age(61-80Yrs) |
3.77469999701674E-08 |
| Normal-vs-Age(81-100Yrs) |
1.175540E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.928400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.197200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.881400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.639160E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.503220E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.289800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.749200E-01 |
| Normal-vs-Grade 2 |
6.387600E-04 |
| Normal-vs-Grade 3 |
3.90440013653404E-10 |
| Normal-vs-Grade 4 |
8.2044000038195E-08 |
| Grade 1-vs-Grade 2 |
1.500330E-03 |
| Grade 1-vs-Grade 3 |
1.033780E-04 |
| Grade 1-vs-Grade 4 |
1.579970E-04 |
| Grade 2-vs-Grade 3 |
6.350100E-04 |
| Grade 2-vs-Grade 4 |
9.263800E-03 |
| Grade 3-vs-Grade 4 |
8.357200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.66037000000063E-05 |
| Normal-vs-ccB subtype |
1.20339999998276E-06 |
| ccA subtype-vs-ccB subtype |
1.401380E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.21279999998336E-06 |
| Normal-vs-N1 |
6.350400E-04 |
| N0-vs-N1 |
2.607400E-01 |
|
|
